AFFY OTC
Affymax, Inc.
1W: -20.0%
1M: +0.0%
3M: +23.1%
YTD: +100.0%
1Y: +77.8%
3Y: -61.0%
5Y: -97.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.0416
Volume6,000
Avg Volume3,135
Beta7.43
Dividend—
Analyst Ratings
Company Info
CEOJonathan Couchman
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2006-12-15
Websiteaffymax.com
630 Fifth Avenue
New York City, NY 10020
US
New York City, NY 10020
US
650 812 8700
About Affymax, Inc.
Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| WALKER JOHN PETER | S-Sale | 16,040 | $1.92 | 2013-08-28 |
| WALKER JOHN PETER | S-Sale | 500 | $1.93 | 2013-08-28 |
| Orwin John A | G-Gift | 15,000 | — | 2013-06-28 |
| Orwin John A | F-InKind | 16,334 | $1.02 | 2013-06-27 |
| Knapp Jeffrey H | M-Exempt | 1,015 | $6.23 | 2013-02-15 |